Diseases, Conditions, Syndromes

Revealing global barriers to curative hep C treatment access

Almost 90% of the 57 million people living with hepatitis C live in low- and middle-income countries, but only half of these countries currently provide curative treatments at an accessible cost, according to a study by UNSW ...

Oncology & Cancer

Sister cells uncover pre-existing resistant states in cancer

In many cancers, such as ovarian cancer, each round of chemotherapy kills the majority of cancer cells, while a small population of them survives through treatment. These cells are typically more resistant for the next cycle ...

Oncology & Cancer

Strategies to shield breast cancer patients from lymphedema

In a global effort to improve the lives of breast cancer survivors, new health research has looked at strategies that can help prevent lymphedema for millions of cancer survivors as a result of damage or removal of their ...

page 5 from 40